Financhill
Back

Nutanix, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
31

NTNX
Nutanix, Inc.

Last Price:
$47.88
Seasonality Move:
-3.58%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
31
Nutanix, Inc. (NTNX) is a Sell

Is Nutanix, Inc. a Buy, Sell or Hold?

  • The current Nutanix, Inc. [NTNX] share price is $47.23. The Score for NTNX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • NTNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

NTNX Stock Price Chart

What is Nutanix, Inc.'s stock price today?

  • The Nutanix, Inc. share price today is $47.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

NTNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.78 Sell
Relative Strength Index (14 RSI): 19.89 Sell
Chaikin Money Flow: -969935 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NTNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.26 Sell
20-day SMA: 55.87 Sell
50-day SMA: 64.54 Sell
200-day SMA: 70.53 Sell
8-day EMA: 48.71 Sell
20-day EMA: 54.3 Sell
50-day EMA: 61.79 Sell
200-day EMA: 67.76 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Nutanix, Inc. Earnings Growth & NTNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.52 per share, and an increase next year of $0.06 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.35 per share.

Nutanix, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):